4
Changes in Ownership
Adaptive Biotechnologies Corp Filed Acc 0001209191-21-026181
CEO and Chairman sold 15,000 shares at an average $41.81 ($627,107)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| ROBINS CHAD M CEO and Chairman | 2021-04-06 | Sale | −1,600 | $41.08 | $65,728 | 1,761,861 | D |
| ROBINS CHAD M CEO and Chairman | 2021-04-06 | Sale | −2,200 | $42.48 | $93,456 | 1,759,661 | D |
| ROBINS CHAD M CEO and Chairman | 2021-04-06 | Sale | −1,200 | $43.08 | $51,696 | 1,758,461 | D |
| ROBINS CHAD M CEO and Chairman | 2021-04-07 | Sale | −3,900 | $40.61 | $158,379 | 1,754,561 | D |
| ROBINS CHAD M CEO and Chairman | 2021-04-07 | Sale | −1,100 | $41.45 | $45,595 | 1,753,461 | D |
| ROBINS CHAD M CEO and Chairman | 2021-04-08 | Sale | −2,943 | $42.04 | $123,724 | 1,750,518 | D |
| ROBINS CHAD M CEO and Chairman | 2021-04-08 | Sale | −1,957 | $43.00 | $84,151 | 1,748,561 | D |
| ROBINS CHAD M CEO and Chairman | 2021-04-08 | Sale | −100 | $43.78 | $4,378 | 1,748,461 | D |
| Open-market sales · 15,000 sh · avg $41.81 · $627,107 | |||||||
Loading xslF345X03/doc4.xml…